Mark M Stevens
Overview
Explore the profile of Mark M Stevens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
316
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winter P, Ramseier M, Navia A, Saksena S, Strouf H, Senhaji N, et al.
bioRxiv
. 2024 Jun;
PMID: 38915726
Efforts to cure BCR::ABL1 B cell acute lymphoblastic leukemia (Ph+ ALL) solely through inhibition of ABL1 kinase activity have thus far been insufficient despite the availability of tyrosine kinase inhibitors...
2.
Stevens M, Kimmerling R, Olcum S, Vacha M, LaBella R, Minnah A, et al.
JCO Precis Oncol
. 2024 Jan;
8:e2300349.
PMID: 38237098
Purpose: Cancer patients with advanced-stage disease have poor prognosis, typically having limited options for efficacious treatment, and genomics-based therapy guidance continues to benefit only a fraction of patients. Next-generation ex...
3.
Hoskins J, Rempoulakis P, Stevens M, Dominiak B
Insects
. 2023 Oct;
14(10).
PMID: 37887813
Exotic tephritid incursions are of high concern to Australia's biosecurity and its horticultural industries. It is vital that Australia remains ready to respond to incursions as they arise, as an...
4.
Elnaggar M, Agte S, Restrepo P, Ram M, Melnekoff D, Adamopoulos C, et al.
J Hematol Oncol
. 2023 May;
16(1):52.
PMID: 37158935
No abstract available.
5.
Kimmerling R, Stevens M, Olcum S, Minnah A, Vacha M, LaBella R, et al.
Commun Biol
. 2023 Jan;
6(1):15.
PMID: 36609595
No abstract available.
6.
Kimmerling R, Stevens M, Olcum S, Minnah A, Vacha M, LaBella R, et al.
Commun Biol
. 2022 Nov;
5(1):1295.
PMID: 36435843
Functional precision medicine offers a promising complement to genomics-based cancer therapy guidance by testing drug efficacy directly on a patient's tumor cells. Here, we describe a workflow that utilizes single-cell...
7.
Elnaggar M, Agte S, Restrepo P, Ram M, Melnekoff D, Adamopoulos C, et al.
J Hematol Oncol
. 2022 Aug;
15(1):109.
PMID: 35978321
Background: Multiple Myeloma (MM) is a progressive plasma cell neoplasm characterized by heterogeneous clonal expansion. Despite promising response rates achieved with anti-BCMA CAR-T cell therapy, patients may still relapse and...
8.
Stevens M, Warren G, Mo J
Pest Manag Sci
. 2021 Nov;
78(3):1000-1007.
PMID: 34761507
Background: The common armyworm Mythimna convecta is an important pest of pastures and graminaceous crops in Australia, but materials currently registered for its control are limited to broad-spectrum compounds incompatible...
9.
Khun K, Ash G, Stevens M, Huwer R, Wilson B
Sci Rep
. 2021 Jan;
11(1):2188.
PMID: 33500474
Kuschelorhynchus macadamiae is a major pest of macadamias in Australia, causing yield losses of up to 15%. Our previous studies have shown the weevil is susceptible to Beauveria bassiana and...
10.
Khun K, Wilson B, Stevens M, Huwer R, Ash G
Insects
. 2020 Sep;
11(10).
PMID: 32992798
Weevils are significant pests of horticultural crops and are largely managed with insecticides. In response to concerns about negative impacts of synthetic insecticides on humans and the environment, entomopathogenic fungi...